These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12437765)

  • 1. Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors.
    Gharagozlou P; Demirci H; Clark JD; Lameh J
    BMC Neurosci; 2002 Nov; 3():19. PubMed ID: 12437765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of opioid ligands in cells expressing cloned mu opioid receptors.
    Gharagozlou P; Demirci H; David Clark J; Lameh J
    BMC Pharmacol; 2003 Jan; 3():1. PubMed ID: 12513698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of opioid ligands at kappa opioid receptors.
    Gharagozlou P; Hashemi E; DeLorey TM; Clark JD; Lameh J
    BMC Pharmacol; 2006 Jan; 6():3. PubMed ID: 16433932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.
    Bot G; Blake AD; Li S; Reisine T
    Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
    Martin NA; Terruso MT; Prather PL
    J Pharmacol Exp Ther; 2001 Jul; 298(1):240-8. PubMed ID: 11408548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic morphine treatment inhibits opioid receptor desensitization and internalization.
    Eisinger DA; Ammer H; Schulz R
    J Neurosci; 2002 Dec; 22(23):10192-200. PubMed ID: 12451120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
    Chaturvedi K; Jiang X; Christoffers KH; Chinen N; Bandari P; Raveglia LF; Ronzoni S; Dondio G; Howells RD
    Brain Res Mol Brain Res; 2000 Sep; 80(2):166-76. PubMed ID: 11038249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors.
    Katsumata S; Minami M; Nakagawa T; Iwamura T; Satoh M
    Eur J Pharmacol; 1995 Nov; 291(3):367-73. PubMed ID: 8719422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of a delta opioid receptor by functional expression.
    Evans CJ; Keith DE; Morrison H; Magendzo K; Edwards RH
    Science; 1992 Dec; 258(5090):1952-5. PubMed ID: 1335167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
    Wang D; Sun X; Sadee W
    J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
    Picker MJ
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
    Cavalli A; Babey AM; Loh HH
    Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine.
    Chen JC; Smith ER; Cahill M; Cohen R; Fishman JB
    Life Sci; 1993; 52(4):389-96. PubMed ID: 8093631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
    Tso PH; Yung LY; Wong YH
    J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells.
    Martin NA; Prather PL
    Mol Pharmacol; 2001 Apr; 59(4):774-83. PubMed ID: 11259622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.